Advances in neuropharmacology : (Record no. 70414)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03997cam a22004578i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 9780429242717 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220531132308.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 190723s2020 onc ob 001 0 eng |
| 040 ## - Cataloging Source | |
| -- | OCoLC-P |
| -- | eng |
| -- | rda |
| -- | OCoLC-P |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429242717 |
| -- | (PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429242719 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429512469 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429512465 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429519321 |
| -- | (electronic bk. : Mobipocket) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 042951932X |
| -- | (electronic bk. : Mobipocket) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780429515897 |
| -- | (electronic bk. : EPUB) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 0429515898 |
| -- | (electronic bk. : EPUB) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781771887977 |
| -- | (hardcover) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1109936077 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC-P)1109936077 |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM315 |
| 072 #7 - | |
| -- | SCI |
| -- | 089000 |
| -- | bisacsh |
| 072 #7 - | |
| -- | MMG |
| -- | bicssc |
| 082 0# - | |
| -- | 615.7/8 |
| -- | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Advances in neuropharmacology : |
| Remainder of title | drugs and therapeutics / |
| Statement of responsibility, etc. | edited by Md. Sahab Uddin, Mamunur Rashid. |
| 264 #1 - | |
| -- | Oakville, ON, Canada ; |
| -- | Palm Bay, Florida, USA : |
| -- | Apple Academic Press, |
| -- | 2020. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 520 ## - | |
| -- | "This new volume, Advances in Neuropharmacology: Drugs and Therapeutics, provides a comprehensive overview of the drugs that act on the central and peripheral nervous systems. It thoroughly describes the diseases that are associated with the nervous system and drugs used their treatment while also looking at the current status of these drugs and their future potential and challenges. This book is divided into three sections that describe the nervous system associated diseases and their treatment as well as current status and future opportunities and challenges. Section 1 focuses on the drugs that affect the functions of the autonomic nervous system to produce therapeutic effects. These drugs may act presynaptically by manipulating the genesis, storage, and secretion, and by blocking the action of neurotransmitters. Some drugs may trigger or impede postsynaptic receptors. Section 2 focuses on drugs that affect the central nervous system, including antianxiety drugs, sedative and hypnotic drugs, antidepressant drugs, antipsychotic drugs, antiepileptic drugs, and many more. It covers the pharmacological management of various diseases, including Alzheimer's, Parkinson's, Huntington's disease, and others. Section 3 offers explanations of neurochemical interactions with the aim to develop drugs that have beneficial effects on neurochemical imbalances. This section demonstrates models to assess the transport of drugs across the blood-brain barrier and nanomedicine to treat brain disorders. This rich compilation provides thorough and extensive research updates on the important advances in neuropharmacological drugs and drug therapy from experienced and eminent academicians, researchers, and scientists from throughout the world. It will be rich resource for professionals, academicians, students, researchers, scientists, and industry professionals around the world in the biomedical, health, and life science fields. Key features: Presents recent advances in neuropharmacology, covering the drugs that act on the central and peripheral nervous systems; Provides extensive explanations of various emerging research in this field; Explores the intricacy of neurological disorders Looks at existing and forthcoming therapeutic drug strategies"-- |
| -- | Provided by publisher. |
| 588 ## - | |
| -- | OCLC-licensed vendor bibliographic record. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Neuropharmacology. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sahab Uddin, Md., |
| Dates associated with a name | 1992- |
| Relator term | editor. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rashid, Mamunur |
| Titles and other words associated with a name | (Professor of pharmacology), |
| Relator term | editor. |
| 856 40 - | |
| -- | Taylor & Francis |
| -- | https://www.taylorfrancis.com/books/9780429242717 |
| 856 42 - | |
| -- | OCLC metadata license agreement |
| -- | http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
No items available.